<SEC-DOCUMENT>0001654954-23-013848-index.html : 20231107
<SEC-HEADER>0001654954-23-013848.hdr.sgml : 20231107
<ACCEPTANCE-DATETIME>20231107103048
ACCESSION NUMBER:		0001654954-23-013848
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20231106
FILED AS OF DATE:		20231107
DATE AS OF CHANGE:		20231107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FSD Pharma Inc.
		CENTRAL INDEX KEY:			0001771885
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39152
		FILM NUMBER:		231382243

	BUSINESS ADDRESS:	
		STREET 1:		FIRST CANADIAN PLACE
		STREET 2:		100 KING STREET WEST, SUITE 4000
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A4
		BUSINESS PHONE:		(416) 854-8884

	MAIL ADDRESS:	
		STREET 1:		FIRST CANADIAN PLACE
		STREET 2:		100 KING STREET WEST, SUITE 4000
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1A4
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>fsd_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
Document 1 - file: fsd_6k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>fsd_ex991.htm
<DESCRIPTION>NEWS RELEASE
<TEXT>
Document 2 - file: fsd_ex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>fsd_ex992.htm
<DESCRIPTION>NEWS RELEASE
<TEXT>
Document 3 - file: fsd_ex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>fsd_ex993.htm
<DESCRIPTION>NEWS RELEASE
<TEXT>
Document 4 - file: fsd_ex993.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>fsd_ex991img2.jpg
<TEXT>
Document 5 - file: fsd_ex991img2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>fsd_ex993img2.jpg
<TEXT>
Document 6 - file: fsd_ex993img2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>fsd_ex992img2.jpg
<TEXT>
Document 7 - file: fsd_ex992img2.jpg

</DOCUMENT>
</SEC-DOCUMENT>